HDLs, immunity, and atherosclerosis
- PMID: 21881500
- DOI: 10.1097/MOL.0b013e32834adac3
HDLs, immunity, and atherosclerosis
Abstract
Purpose of review: HDLs possess several physiological activities that may explain their antiatherosclerotic properties. Among them, the most relevant is the ability of HDL to promote the efflux of excess cholesterol from peripheral tissues to the liver for excretion.
Recent findings: The ability of HDL to promote cholesterol efflux results also in the modulation of a series of responses in the immune cells involved in atherosclerosis, including monocyte-macrophages, B and T lymphocytes. HDL also acts as a reservoir for a number of biologically active substances that may impact the immune system, and as the HDL composition varies to a large extent during inflammation.
Summary: The understanding of how these interactions take place and how biologically active substances can be delivered to relevant targets during atherogenesis is of great interest and may provide a better understanding for the role of HDL in atherogenesis.
Similar articles
-
Emerging role of high density lipoproteins as a player in the immune system.Atherosclerosis. 2012 Jan;220(1):11-21. doi: 10.1016/j.atherosclerosis.2011.06.045. Epub 2011 Jul 2. Atherosclerosis. 2012. PMID: 21783193 Review.
-
High-density lipoprotein metabolism and endothelial function.Curr Opin Endocrinol Diabetes Obes. 2010 Apr;17(2):166-70. doi: 10.1097/MED.0b013e32833727ee. Curr Opin Endocrinol Diabetes Obes. 2010. PMID: 20125006 Review.
-
High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy.Arthritis Rheumatol. 2020 Jan;72(1):20-30. doi: 10.1002/art.41059. Epub 2019 Nov 26. Arthritis Rheumatol. 2020. PMID: 31350818 Free PMC article. Review.
-
High-density Lipoprotein and Inflammation and Its Significance to Atherosclerosis.Am J Med Sci. 2016 Oct;352(4):408-415. doi: 10.1016/j.amjms.2016.06.014. Epub 2016 Jun 28. Am J Med Sci. 2016. PMID: 27776723 Review.
-
The rationale for using apoA-I as a clinical marker of cardiovascular risk.J Intern Med. 2006 May;259(5):447-54. doi: 10.1111/j.1365-2796.2006.01647.x. J Intern Med. 2006. PMID: 16629850 Review.
Cited by
-
Low HDL Cholesterol Efflux Capacity Indicates a Fatal Course of COVID-19.Antioxidants (Basel). 2022 Sep 21;11(10):1858. doi: 10.3390/antiox11101858. Antioxidants (Basel). 2022. PMID: 36290581 Free PMC article.
-
HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases.Cells. 2021 Apr 29;10(5):1061. doi: 10.3390/cells10051061. Cells. 2021. PMID: 33947039 Free PMC article. Review.
-
The Role of Monocytes and Macrophages in Human Atherosclerosis, Plaque Neoangiogenesis, and Atherothrombosis.Mediators Inflamm. 2019 Apr 4;2019:7434376. doi: 10.1155/2019/7434376. eCollection 2019. Mediators Inflamm. 2019. PMID: 31089324 Free PMC article. Review.
-
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis.Curr Atheroscler Rep. 2018 Feb 14;20(3):12. doi: 10.1007/s11883-018-0715-0. Curr Atheroscler Rep. 2018. PMID: 29445885 Review.
-
Lipid testing in infectious diseases: possible role in diagnosis and prognosis.Infection. 2017 Oct;45(5):575-588. doi: 10.1007/s15010-017-1022-3. Epub 2017 May 8. Infection. 2017. PMID: 28484991 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials